These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9391131)

  • 21. Abnormalities in stress proteins in prion diseases.
    Tatzelt J; Voellmy R; Welch WJ
    Cell Mol Neurobiol; 1998 Dec; 18(6):721-9. PubMed ID: 9876878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion protein diversity and disease in the transmissible spongiform encephalopathies.
    Priola SA
    Adv Protein Chem; 2001; 57():1-27. PubMed ID: 11447687
    [No Abstract]   [Full Text] [Related]  

  • 24. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
    Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
    PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
    Vorberg I; Raines A; Priola SA
    J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
    Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion diseases and the 'protein only' hypothesis: a theoretical dynamic study.
    Laurent M
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):35-9. PubMed ID: 8761449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion infection: seeded fibrillization or more?
    Birkmann E; Riesner D
    Prion; 2008; 2(2):67-72. PubMed ID: 19098436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion protein PrPc interacts with molecular chaperones of the Hsp60 family.
    Edenhofer F; Rieger R; Famulok M; Wendler W; Weiss S; Winnacker EL
    J Virol; 1996 Jul; 70(7):4724-8. PubMed ID: 8676499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro conversion of normal prion protein into pathologic isoforms.
    Bossers A; Rigter A; de Vries R; Smits MA
    Clin Lab Med; 2003 Mar; 23(1):227-47. PubMed ID: 12733434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion diseases and their biochemical mechanisms.
    Cobb NJ; Surewicz WK
    Biochemistry; 2009 Mar; 48(12):2574-85. PubMed ID: 19239250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion seeded conversion and amplification assays.
    Orrú CD; Caughey B
    Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.